Who may participate
Joining a clinical trial is an important and personal decision. Thank you for your interest in the AcRIS study.
You may be eligible for the AcRIS study if you:
- are relatively healthy,
- have not received any doses of a COVID-19 vaccine, and
- are willing to complete daily voice recordings and respiratory symptom reporting via a phone app for 6-8 weeks.
There are other requirements for participation in the study. The prescreening and consent process will help to explain these to you.
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
If you choose to download the app and sign the informed consent, you will be asked health-related questions to see if you’re eligible to participate. The AcRIS study is conducted virtually through a mobile app, with no in person visits. You will take daily self-assessments in the app, including voice recordings and reporting of respiratory symptoms for about 8 weeks.
In addition, you will be sent two nasal swab self-collection kits. You will complete the first swab when the kit is received, and the second swab either when you report symptoms of respiratory illness or at the end of week 6 of your study participation. You will be provided your swab test results.
If you test positive for COVID-19, Influenza, or RSV on either swab, you will continue participating in the trial for 8 weeks. If both swabs are negative for all three viruses, your participation ends after week 6.
Download the mobile app to see if you may qualify
To see if you may qualify for the AcRIS study, you will begin by downloading the study app on either an iPhone® or AndroidTM mobile phone – the study app cannot be used on tablet devices. Once you’ve downloaded the app, you can complete the pre-screener to determine if you are eligible. If you are eligible and choose to participate, you will complete daily study assessments using the app.
The AcRIS study is conducted entirely through the mobile app and will not require you to visit a study clinic to participate. Thank you for your consideration.
App Store is a service mark of Apple Inc., registered in the U.S. and other countries. Google Play and the Google Play logo are trademarks of Google LLC.
About COVID-19, Influenza, and RSV
Respiratory illnesses are often hard to distinguish because symptoms may be similar across different illnesses. This study is focusing on 3 illnesses: SARS-CoV-2, which is the strain of coronavirus that causes coronavirus disease 2019, also known as COVID-19; Influenza, which is commonly known as "the flu", and is an infectious disease caused by an influenza virus; and RSV, which is a common type of virus that can cause respiratory infection ranging from mild cold-like symptoms to severe lower respiratory tract disease.
Frequently Asked Questions
Will I need to go into a clinic to participate in this trial?
No, this trial is conducted entirely through a mobile app. Swabs are done by you, in your home and mailed away for testing.
How many times per day do I need to take the self-assessment?
Self-assessments are completed once per day.
How long will I need to participate in the daily self-assessments?
Your participation will last between 6 and 8 weeks. You will be asked to take the self-assessments each day of your participation. The daily assessments are expected to take about 2-4 minutes to complete.
Do I need to send my self-swab kit to a lab?
Yes. The self-swab kit will come with detailed instructions on how to self-administer as well as how and where to send in the completed swab.